“Quick question: will the government of India have Rs 80 billion available next year? Because that’s what @MoHFW_INDIA needs, to buy and distribute the vaccine to everyone in India,” he tweeted.
Fast question; Will the government of India have Rs 80 billion available next year? Because that’s w… https://t.co/jnlpTJda2B
– Adar Poonawalla (@adarpoonawalla) 1601112818000
This is the next “challenge” we have to tackle, he said, also pointing to the prime minister’s office.
I ask this question, because we need to plan and guide vaccine manufacturers both in India and abroad to service … https://t.co/2AO0YzzS7R
– Adar Poonawalla (@adarpoonawalla) 1601116719000
“I ask this question because we need to plan and guide vaccine manufacturers both in India and abroad to serve the needs of our country in terms of procurement and distribution,” Poonawalla added.
SII has signed an agreement to manufacture the possible vaccine developed by the Jenner Institute at the University of Oxford in collaboration with the British-Swedish pharmaceutical company AstraZeneca.
Previously, the SII had announced that it would make the Oxford vaccine available at USD 3 for low- and middle-income countries, including India.
.
